Go Pro

Cartesian Therapeutics (RNAC) Institutional Ownership

Cartesian Therapeutics logo
$10.59 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$10.71 +0.12 (+1.10%)
As of 07/2/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)

Current
Institutional Ownership
Percentage
86.95%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$7.43M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$3.41M
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RNAC Institutional Buying and Selling by Quarter

Cartesian Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Renaissance Technologies LLC67,300$414K0.0%+63.7%0.229%
5/14/2026Public Employees Retirement System of Ohio13,000$80K0.0%-16.1%0.044%
5/14/2026Sei Investments Co.12,764$78K0.0%N/A0.043%
2/18/2026XTX Topco Ltd10,238$74K0.0%-61.0%0.039%
2/18/2026Millennium Management LLC164,366$1.19M0.0%+548.2%0.632%
2/18/2026683 Capital Management LLC280,000$2.02M0.1%+21.7%1.077%
2/17/2026Jain Global LLC16,724$121K0.0%N/A0.064%
2/17/2026Public Employees Retirement System of Ohio15,500$112K0.0%N/A0.060%
2/16/2026Squarepoint Ops LLC18,213$131K0.0%N/A0.070%
2/13/2026Marshall Wace LLP178,140$1.28M0.0%+110.1%0.685%
2/13/2026Walleye Capital LLC43,878$316K0.0%N/A0.169%
2/13/2026Wells Fargo & Company MN11,762$85K0.0%+49.2%0.045%
2/12/2026Renaissance Technologies LLC41,100$296K0.0%N/A0.158%
2/12/2026Miller Financial Services LLC13,643$98K0.1%+17.2%0.052%
2/11/2026Erste Asset Management GmbH271,705$1.96M0.0%+4.5%1.045%
2/9/2026Geode Capital Management LLC255,539$1.84M0.0%+5.7%0.983%
2/3/2026Privium Fund Management B.V.172,500$1.24M0.2%N/A0.663%
1/30/2026R Squared Ltd10,308$74K0.0%N/A0.040%
11/17/2025Jacobs Levy Equity Management Inc.30,001$307K0.0%-27.4%0.115%
11/17/2025Millennium Management LLC25,357$259K0.0%N/A0.098%
11/14/2025Bridgeway Capital Management LLC25,000$256K0.0%N/A0.096%
11/7/2025GSA Capital Partners LLP86,095$880K0.1%+106.9%0.331%
11/7/2025Vanguard Group Inc.520,722$5.32M0.0%+4.9%2.003%
11/3/2025AlphaQuest LLC6,924$71K0.0%+64.6%0.027%
8/15/2025Bank of America Corp DE13,933$145K0.0%+133.0%0.054%
8/15/2025683 Capital Management LLC219,000$2.28M0.1%+46.0%0.842%
8/14/2025MPM Bioimpact LLC686,007$7.13M1.2%-13.2%2.638%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,056$53K0.0%-16.0%0.019%
8/13/2025Marshall Wace LLP82,630$859K0.0%+114.0%0.318%
8/13/2025Virtus Investment Advisers LLC9,183$95K0.0%+12.5%0.035%
8/12/2025JPMorgan Chase & Co.6,080$63K0.0%-96.9%0.023%
8/12/2025Miller Financial Services LLC11,643$121K0.2%N/A0.045%
8/8/2025Geode Capital Management LLC218,927$2.28M0.0%-2.9%0.844%
7/31/2025AlphaQuest LLC4,207$44K0.0%-41.5%0.016%
6/27/2025Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/29/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
5/23/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.170%
5/16/2025Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/16/2025683 Capital Management LLC150,000$1.98M0.1%+20.0%0.578%
5/15/2025MPM Bioimpact LLC790,779$10.42M1.8%+9.7%3.049%
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
5/15/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.172%
5/14/2025AlphaQuest LLC7,191$95K0.0%N/A0.028%
5/14/2025Erste Asset Management GmbH260,011$3.43M0.0%+49.8%1.002%
5/13/2025Twin Focus Capital Partners LLC15,000$198K0.0%+25.0%0.058%
5/12/2025Nuveen LLC27,869$367K0.0%N/A0.107%
5/9/2025Deutsche Bank AG7,424$98K0.0%+104.1%0.029%
5/9/2025Charles Schwab Investment Management Inc.29,303$386K0.0%+9.3%0.113%
4/30/2025Alps Advisors Inc.19,392$256K0.0%-5.6%0.075%
4/29/2025Bank of New York Mellon Corp20,937$276K0.0%+7.9%0.081%
4/8/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
2/17/2025Two Sigma Investments LP11,812$212K0.0%-8.5%0.046%
2/17/2025MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837%
2/17/2025Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$104K0.0%+44.8%0.023%
2/17/2025Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239%
2/17/2025Bank of America Corp DE11,690$209K0.0%+54.4%0.046%
2/17/2025683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492%
2/14/2025Northern Trust Corp95,030$1.70M0.0%+50.6%0.374%
2/14/2025Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014%
2/14/2025MetLife Investment Management LLC6,667$119K0.0%N/A0.026%
2/13/2025Barclays PLC19,099$342K0.0%+64.5%0.075%
2/13/2025Renaissance Technologies LLC13,800$247K0.0%N/A0.054%
2/13/2025Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019%
2/12/2025Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870%
2/12/2025JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081%
2/11/2025Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020%
2/10/2025Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683%
2/6/2025Charles Schwab Investment Management Inc.26,803$480K0.0%+40.7%0.105%
2/4/2025Bank of New York Mellon Corp19,407$348K0.0%+28.5%0.076%
1/31/2025New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015%
1/30/2025Rhumbline Advisers10,201$183K0.0%+10.0%0.040%
1/27/2025Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018%
1/24/2025China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021%
12/26/2024JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216%
11/19/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/16/2024Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534%
11/15/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/15/2024State Street Corp157,495$2.54M0.0%+2.5%0.620%
11/15/2024Ikarian Capital LLC52,193$841K0.1%-78.5%0.205%
11/13/2024Great Point Partners LLC200,000$3.22M0.9%N/A0.787%
11/13/2024BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006%
11/13/2024FMR LLC2,851,830$45.97M0.0%+458.3%11.219%
10/23/2024Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074%
9/16/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
9/16/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
9/16/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/27/2024Logos Global Management LP90,000$2.43M0.2%N/A0.506%
8/15/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/14/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
8/14/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
8/14/2024Marshall Wace LLP30,038$811K0.0%N/A0.140%
8/14/2024Logos Global Management LP90,000$2.43M0.2%N/A0.421%
8/9/2024Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096%
8/6/2024Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178%
8/1/2024Rhumbline Advisers8,487$229K0.0%-93.5%0.048%
7/26/2024Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112%
7/22/2024Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010%
5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098%
5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052%
5/10/2024Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172%


RNAC Institutional Ownership - Frequently Asked Questions

During the previous two years, 57 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), Siren L.L.C. ($7.42M), MPM Bioimpact LLC ($7.13M), Citadel Advisors LLC ($5.64M), Vanguard Group Inc. ($5.32M), Great Point Partners LLC ($3.22M), and State Street Corp ($2.54M).Learn more on Cartesian Therapeutics' institutional investors.

86.95% of Cartesian Therapeutics' stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings.

Of the 47 institutional investors that purchased Cartesian Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.34M), Great Point Partners LLC ($200K), 683 Capital Management LLC ($193.57K), Logos Global Management LP ($180K), Privium Fund Management B.V. ($172.50K), Marshall Wace LLP ($167.40K), and Millennium Management LLC ($164.37K).

Institutional investors have bought a total of 926,378 shares in the last 24 months. This purchase volume represents approximately $7.43M in transactions.

The following institutional investors have sold Cartesian Therapeutics stock in the last 24 months: JPMorgan Chase & Co. ($188.96K), MPM Bioimpact LLC ($104.77K), XTX Topco Ltd ($16.02K), Jacobs Levy Equity Management Inc. ($11.32K), Geode Capital Management LLC ($6.57K), AlphaQuest LLC ($2.98K), and Public Employees Retirement System of Ohio ($2.50K).

Institutional investors have sold a total of 334,087 shares in the last 24 months. This volume of shares sold represents approximately $3.41M in transactions.



This page (NASDAQ:RNAC) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners